TEOCO joins Google Cloud Partner Advantage Program
FAIRFAX, VA., USA – 5 May 2022 – TEOCO, the leading provider of analytics, assurance…
Year: 2022
Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial
The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in…
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
– $209.7 Million Cash and Cash Equivalents at March 31, 2022 – – Over 120…
Turning Point Therapeutics Announces Pipeline Expansion, Licensing of TPX-4589 (LM-302), A Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate for Gastrointestinal Cancers, From Lanova Medicines
Strategic Expansion of Turning Point Precision Oncology Portfolio TPX-4589 (LM-302) Currently in Two Ongoing Phase…
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from…
Hillstream BioPharma to Present at BioNJ’s 12th Annual BioPartnering Virtual Conference Held on May 9- 13, 2022
Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring…
Enlivex Announces Issuance of Two U.S. Patents Covering Methods of Treating Sepsis with Allocetra
Nes-Ziona, Israel, May 05, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Coherus BioSciences Appoints Charlie Newton to Board of Directors
– Biotechnology Chief Financial Officer and highly regarded former healthcare investment banker brings decades of…
Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S….
Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education
Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE…
Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma NEW YORK, May 05, 2022…
ABVC BioPharma Announces Streamlined Vitargus® Manufacturing Process
New Process Improves Quality and Lowers Cost Fremont, CA, May 05, 2022 (GLOBE NEWSWIRE) —…
Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
SCYNEXIS to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12
JERSEY CITY, N.J., May 05, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
Acer Therapeutics to Participate in H.C. Wainwright Global Investment Conference
NEWTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting
IRVINE, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic…
Synthetic Biologics Announces Formation of Scientific Advisory Board to Advance Oncology Pipeline
Scientific Advisory Board of leading experts in oncolytic adenoviruses and gene therapies strengthens transformative clinical…
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
Revolo Biotherapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
NEW ORLEANS and LONDON, May 05, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…